Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IMTX · NASDAQ · Biological Products, (No Diagnostic Substances) · Foreign private issuer
Immatics (IMTX) · oqro.io/stocks/IMTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$6.39−0.13 (−1.99%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Longaeva Partners L.P. no longer reported IMTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Baker Bros. Advisors LP disclosed a reduced position in IMTX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. disclosed an increased position in IMTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
RTW Investments, LP disclosed an increased position in IMTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Baker Bros. Advisors LP disclosed a reduced position in IMTX for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in IMTX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP disclosed an increased position in IMTX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Montanova Capital, LLC disclosed a reduced position in IMTX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP no longer reported IMTX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
RTW Investments, LP disclosed an increased position in IMTX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Baker Bros. Advisors LP disclosed an increased position in IMTX for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Montanova Capital, LLC disclosed an increased position in IMTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in IMTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Baker Bros. Advisors LP disclosed an increased position in IMTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. no longer reported IMTX for Q2 2025Fund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Montanova Capital, LLC disclosed an increased position in IMTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in IMTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in IMTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
RTW Investments, LP disclosed an increased position in IMTX for Q1 2025Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in IMTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Montanova Capital, LLC disclosed a new position in IMTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in IMTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed an increased position in IMTX for Q4 2024Fund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed an increased position in IMTX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Montanova Capital, LLC no longer reported IMTX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed an increased position in IMTX for Q3 2024SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed a reduced position in IMTX for Q2 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in IMTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Baker Bros. Advisors LP disclosed an increased position in IMTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP disclosed a reduced position in IMTX for Q4 2024Source